2022 Workshop Sessions

Tuesday, November 1, 2022
10:30 AM-12:00 PM
A 1 – Foundations of Medication Assisted Treatment
Location: Holiday 1-3, Level 2 Primary Presenter: Marian Currens, CRNP – University of Maryland Medical Center, Center for Addiction Medicine Co-Presenter: G. Malik Burnett, MD, MBA, MPH – Employee Health and Safety, University of Maryland Midtown Campus Patient Care & Best Practices
1.5 Credits

10:30 AM-12:00 PM
A2 – Systems-Level Partnerships in Implementing Innovative Enhancements in the Treatment of Opioid Use Disorders
Location: Holiday 4, Level 2 Primary Presenter: Kisha M. Winston-Watkins, MBA, LCSWC (she/her/hers)- Behavioral Health System Baltimore (BHSB) Co-Presenter: Salima Montes, LCPC,CAC-AD – Behavioral Health Administration
Co-Presenter: Theresa E. Tassey, MD, MPH, MS- Medis Logica, LLC Community Partners & Continuum of Care
1.5 Credits

10:30 AM-12:00 PM
A3 – The Future of Peer-Led Meetings: Successes in Virtual All-Recovery Support Meetings During COVID-19
Location: Holiday 5, Level 2
Speaker: Michael Litterer, CHES, CPS, FHELA- RWJBarnabas Health
Speaker: Gina Zaccagnino, LCSW – Institute for Prevention and Recovery Patient Care & Best Practices
1.5 Credits

10:30 AM-12:00 PM
A4 – Legal and Policy Strategies to Improve Access to Medications for Opioid
Use Disorder in the Criminal Legal System
Location: Peale A-C, Level 1 Primary Presenter: Gabrielle R. de la Gueronniere, J.D./Law- Legal Action Center
Co-Presenter: Deborah A. Reid, J.D. – Legal Action Center
Co-Presenter: Rebekah Joab, J.D. – Legal Action Center Public Policy/Regulatory and Financial Issues
1.5 Credits

10:30 AM-12:00 PM
AS – Harnessing Your Expertise: AATOD Media Training with Reporting on Addiction
Location: Johnson A-B, Level 1
Primary Presenter: Jonathan J. Stoltman, PhD (he/him/his)- Reporting on Addiction; Opioid
Policy Institute
Co-Presenter: Ashton Marra, MS – Reporting on Addiction
Co-Presenter: Mishka Terplan, MD – Friends Research Institute Community Partners & Continuum of Care
1.5 Credits

1 :30 PM -3:00 PM
1 – Effectively Treating the Aging and Elderly in Opioid Treatment Programs: A Comprehensive Model
Location: Holiday 1-3, Level 2 Primary
Presenter: Linda Hurley, MA- CODAC Behavioral Healthcare
Co-Presenter: Andrew C. Stone, MD- CODAC Behavioral Healthcare
Co-Presenter: Catherine DeGood, DO – CODAC Behavioral Healthcare Patient Care & Best Practices
1.5 Credits

1 :30 PM -3:00 PM
2 – A Comparative Effectiveness Trial of Extended-Release Medications with Individuals Leaving Jail: Lessons Learned Location: Johnson A-B, Level 1 Primary
Presenter: Michael S. Gordon, DPA- Friends Research Institute
Co-Presenter: Marc Fishman, MD – Maryland Treatment Centers
Co-Presenter: Mary Ann Thompson – St. Mary’s County Detention and Rehabilitation Center Opioid Abuse as a Public Health Crisis and Overdose as an Epidemic
1.5 Credits

 

1:30 PM – 3:00 PM
3 – Hub and Spoke Model lmplementation-9 years Later
Location: Peale A-C, Level 1 Primary
Presenter: John Brooklyn, MD -Howard Center Chittenden Clinic and BMRT St. Albans Hub
Co-Presenter: Anthony E. Folland, BA-State of Vermont
Co-Presenter: Beth A. Rutkowski, MPH -UCLA Integrated Substance Abuse Programs Patient Care & Best Practices
1.5 Credits

4:00 PM – 5:30 PM
B1 – Building Therapeutic Partnerships: The Most Important Evidenced-Based Practice
Location: Holiday 1-3, Level 2
Primary Presenter: Alan Nolan, LCSW -Connecticut Counseling Centers, Inc. Patient Care & Best Practices
1.5 Credits

4:00 PM – 5:30 PM
B2 – Reverse the Cycle: Peer Interventions & Hospital-Based MAT Induction in Rural Appalachia
Location: Holiday 4, Level 2
Primary Presenter: Sadie Smith, MSW -Mosaic Group
Co-Presenter: Brian Myers, MBA, MTS, CMPE -Appalachian Regional Healthcare Community Partners & Continuum of Care
1.5 Credits

4:00 PM – 5:30 PM
B3 – Building Workforce Capacity to Address Diversity, Equity, and Inclusion: Developing a Shared Language
Location: Holiday 5, Level 2 Primary
Presenter: Deena M. Murphy, PhD -Opioid Response Network
Co-Presenter: Nicole M. Augustine, MPH, MCHES, PS – Opioid Response Network Workforce Development
1.5 Credits

4:00 PM – 5:30 PM
B4 – Injectable Opioid Agonist Therapy in a Perinatal Acute Care Setting
Location: Peale A-C, Level 1
Primary Presenter: Charissa Patricelli, MD (she/her/hers)-Women’s Health Research Institute Patient Care & Best Practices
1.5 Credits

4:00 PM – 5:30 PM
B5 – MAT in Corrections: 5 Years of Increasing Success. A How-To and Why Story
Location: Johnson A-B, Level 1
Primary Presenter: Linda Hurley, MA-CODAC Behavioral Healthcare
Co-Presenter: Rosemarie Martin, PhD (she/her/hers)-Brown University School of Public Health
Co-Presenter: Justin Berk, MD MPH MBA- Rhode Island Department of Corrections Community Partners & Continuum of Care
1.5 Credits

4:00 PM – 5:30 PM
B5 – MAT in Corrections: 5 Years of Increasing Success. A How-To and Why Story
Location: Johnson A-B, Level 1
Primary Presenter: Linda Hurley, MA-CODAC Behavioral Healthcare
Co-Presenter: Rosemarie Martin, PhD (she/her/hers)-Brown University School of Public Health
Co-Presenter: Justin Berk, MD MPH MBA- Rhode Island Department of Corrections Community Partners & Continuum of Care
1.5 Credits

4:00 PM – 5:30 PM
B5 – MAT in Corrections: 5 Years of Increasing Success. A How-To and Why Story
Location: Johnson A-B, Level 1
Primary Presenter: Linda Hurley, MA-CODAC Behavioral Healthcare
Co-Presenter: Rosemarie Martin, PhD (she/her/hers)-Brown University School of Public Health
Co-Presenter: Justin Berk, MD MPH MBA- Rhode Island Department of Corrections Community Partners & Continuum of Care
1.5 Credits

Wednesday, November 2, 2022
1 :30 PM – 3:00 PM
C1 – Hepatitis C Testing and Treatment in Opioid Treatment Programs
Location: Holiday 1-3, Level 2
Primary Presenter: Ally Lor, BSN, RN, CARN -Community Medical Services
Co-Presenter: Michelle M. Byron, LPN -Community Medical Services Patient Care & Best Practices
1.5 Credits

1 :30 PM – 3:00 PM
C2 – Collaborating to Address Systemic Racism in Substance Use Disorder Treatment: Anti-Racist Strategies
Location: Holiday 4, Level 2
Primary Presenter: Deena M. Murphy, PhD -Opioid Response Network
Co-Presenter: Laurie Krom, MS -University of Missouri – Kansas City
Co-Presenter: Holly N. Hagle, PhD -Addiction Technology Transfer Center Network Coordinating Office Patient Care & Best Practices
1.5 Credits

1 :30 PM – 3:00 PM
C3 – An Integrated and Collaborative Approach to Addressing Opioid Misuse and Overdose in Anne Arundel County
Location: Holiday 5, Level 2
Primary Presenter: Tracy Schulden, LCSW-C -Anne Arundel County Health Department
Co-Presenter: Rebecca Trott, LCSW-C -Anne Arundel County Health Department Opioid Abuse as a Public Health Crisis and Overdose as an Epidemic
1.5 Credits

1:30 – 3:00 PM
C4 – Law and Medicine: Partnerships through the Opioid Response Network
Location: Peale A-C, Level 1
Primary Presenter: Kathryn Cates-Wessel, BA-American Academy of Addiction Psychiatry
Co-Presenter: Rosemarie Martin, PhD (she/her/hers)-Brown University School of Public Health
Co-Presenter: Tara L. Kunkel, MSW -Rulo Strategies LLC Community Partners & Continuum of Care
1.5 Credits

1 :30 PM -3:00 PM
C5 – Avoiding Burnout and Compassion Fatigue: How Self-Care among Substance Use Professionals Enhances Patient Care
Location: Johnson A-B, Level 1
Primary Presenter: Maureen O’Neill Biggs, MSW, LCSW -Connecticut Counseling Centers, Inc.
Co-Presenter: Alan Nolan, LCSW -Connecticut Counseling Centers, Inc. Workforce Development
1.5 Credits

3:15 PM-4:45 PM
01 – Substance Use Disorder in Pregnancy: Treatment throughout the Four Trimesters
Location: Holiday 1-3, Level 2
Primary Presenter: Hillary Tamar, MD (she/her/hers)-Community Medical Services Patient Care & Best Practices
1.5 Credits

3:15 PM-4:45 PM
02 – The Power of Collaboration: Lessons Learned from OTP Partnerships with Massachusetts Jails and Prisons
Location: Holiday 4, Level 2
Primary Presenter: Tracy A. Desruisseaux, LADC-I -Spectrum Health Systems
Co-Presenter: Lori Canane, LADC II -Spectrum Health Systems
Co-Presenter: Sharif Nankoe, MD, MPA, MA, FASAM -Spectrum Health Systems Community Partners & Continuum of Care
1.5 Credits

3:15 PM-4:45 PM
03 – Clinical Supervision Demands in the Substance Use Disorder Field: An Examination of Impact on Therapist Professional Development
Location: Holiday 5, Level 2 Primary Presenter: Julie V. Achtyl, MS, LMHC, Master CASAC, NCC, ACS -URMC/Strong Recovery
1.5 Credits

3:15 PM-4:45 PM
04 – Merging the Cultures of Behavioral Health and Law Enforcement to Create a Collaborative Team to Address Opioid Overdose
Location: Peale A-C, Level 1 Primary
Presenter: Daniel Barden, MS – CODAC Health Recovery & Wellness, Inc.
Co-Presenter: Larry Onate, MD – CODAC Health Recovery & Wellness, Inc
Co-Presenter: Ericka Stropka, B.S. – Tucson Police Department Community Partners & Continuum of Care
1.5 Credits

3:15 PM-4:45 PM
05 – Civil Rights Protections for Parents in Child Welfare Services and in Recovery from an Opioid Use Disorder
Location: Johnson A-B, Level 1 Primary
Presenter: Nancy K. Young, PhD – National Center on Substance Abuse and Child Welfare
Co-Presenter: Carla Carter, JD – U.S. Department of Health and Human Services Opioid Abuse as a Public Health Crisis and Overdose as an Epidemic
1.5 Credits

 

Thursday, November 3, 2022
8:15AM – 9:45AM
E1 – Integrated Treatment of OUD and Co-occurring Mental Health Disorders
Location: Holiday 1, Level 2 Primary Presenter: Jeffrey H. Hsu, MD – Johns Hopkins University School of Medicine Patient Care & Best Practices
1.5 Credits

8:15AM – 9:45AM
E2 – NJ’s Integrated Opioid Treatment and Substance Exposed Infant Program: Improving Outcomes for Pregnant and Postpartum Women and Their Babies
Location: Holiday 2-3, Level 2
Primary Presenter: Christine K. Scalise, MA, LPC, LCADC – NJ Department of Human Services, Division of Mental Health and Addiction Services
Co-Presenter: Katherine C. Findley, PhD, MSW – NJ Department of Human Services, Division of Mental Health and Addiction Services
Co-Presenter: Suzanne V. Borys, EdD – NJDMHAS Patient Care & Best Practices
1.5 Credits

8:15AM-9:45AM
E3 – Person-Centered OTP Regulations: Opportunities for State-Level Reform
Location: Holiday 4-6, Level 2
Primary Presenter: Frances McGaffey, MPP – The Pew Charitable Trusts
Co-Presenter: Vanessa Baaklini, MSW- The Pew Charitable Trusts
Co-Presenter: Ryan Mueller, M.Ed, LPC, LAC (he/him/his)- Behavioral Health Administration
Public Policy/Regulatory and Financial Issues
1.5 Credits

8:15AM-9:45AM
E4 – Mile Square Methadone Clinic: An Integrated Collaborative Care Model in a Community Federally Qualified Health Center (FQHC)
Location: Peale A-C, Level 1 Primary Presenter: Nicole M. Gastala, MD (she/her/hers)- University of Illinois – Mile Square Health Center
Co-Presenter: Christine Neeb, MD – University of Illinois – Mile Square Health Center
Co-Presenter: Maria Bruni, PhD – Family Guidance Centers, Inc. Community Partners & Continuum of Care
1.5 Credits

8:15AM – 9:45AM
ES – Addressing Barriers to Wellness and Recovery with Medical and Psychiatric Care Co-located in an Opioid Treatment Program
Location: Johnson A-B, Level 1 Primary Presenter: Aditi Ringwala, MD – University of Maryland School of Medicine
Co-Presenter: Kate Dunn, MSN, RN, CNL (she/her/hers)- University of Maryland Faculty Physicians, Inc
Co-Presenter: Aaron D. Greenblatt, MD – University of Maryland School of Medicine
Patient Care & Best Practices
1.5 Credits

10:00 AM -11 :30 AM
F1 – Improving Cross-System Collaboration to Reduce Stigma and Increase Access to Medication-Assisted Treatment Services
Location: Holiday 2-3, Level 2
Primary Presenter: Latonya Adjei-Tabi, MPA- National Center on Substance Abuse and Child Welfare
Co-Presenter: Nancy K. Young, PhD – National Center on Substance Abuse and Child Welfare Community Partners & Continuum of Care
1.5 Credits

10:00 AM – 11 :30 AM
F3 – Understanding Potential Legal Liability for Hospitals When Emergency Departments Do Not Offer Evidence-Based Substance Use Disorder Services
Location: Holiday 4-6, Level 2 Primary
Presenter: Sika Yeboah-Sampong, J.D. -Legal Action Center
Co-Presenter: Ellen M. Weber, J.D. -Legal Action Center
Patient Care & Best Practices
1.5 Credits

10:00 AM – 11 :30 AM
F4 – The Role of Opioid Treatment Programs in Implementing the National Drug Control Strategy
Location: Peale A-C, Level 1
Primary Presenter: Robert A. Kent, JD -White House Office of National Drug Control Policy
Co-Presenter: Elizabeth Connolly, MPA-Office of National Drug Control Policy
Public Policy/Regulatory and Financial Issues
1.5 Credits

10:00 AM – 11 :30 AM
F5 – Strategic Productivity, Engagement and Retention of Staff
Location: Johnson A-B, Level 1
Primary Presenter: Joshua Nirella, MS -Acadia Healthcare Workforce Development
1.5 Credits

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
  • View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
  • 💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
  • 💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
  • 3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
  • Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
  • Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2024 Conference, �The world’s premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

The 2024 AATOD Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. The registrants are decision-makers with purchasing power for their treatment centers and are looking for new products, services, and information to improve their patient treatment.

To become an exhibitor today —> https://bit.ly/48ZKMRX
  • TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION

💻 View the latest Conference Video Message from AATOD's President, Mark W. Parrino bit.ly/48y815w,
for the most up-to-date details regarding the upcoming #aatod2024 Conference -
The world's premier training conference event for the treatment of Opioid Use Disorder. #OUD 

Registration ➡️ www.aatodconference.com
  • TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION #aatod2024

TODAY is the last day to take advantage of the discounted registration rate. #aatod2024 is the world’s premier training conference event for the treatment of #OUD.

For registration and hotel information ➡️ bit.ly/3Ue57Q6.

We look forward to seeing you in Las Vegas!
  • #aatod2024 Conference Update. Comprehensive Listing/Descriptions of Workshops, Posters, and Hot Topic Roundtable Conference Sessions are now available ➡️ http://bit.ly/3Ue57Q6.

The workshop committee is pleased to present a dynamic workshop lineup that includes extremely rich and diverse educational content for all disciplines. You will hear from experts who will share the latest research and developments relating to opioid use disorders and treatment. The workshop lineup will include state of the art information on diverse areas of focus such as patient care and best practices, building community partnerships and collaborations, public policy and regulatory changes, workforce development, quality assurance, and financial reimbursement. There will be workshops that focus on emerging treatment trends and developments such as the fentanyl epidemic, mobile opioid treatment programs, regulatory changes, expansion of treatment services in rural areas, integrating treatment with the corrections systems, and integrating harm reduction initiatives. For those newer to the field or those who want a refresher on the basics, we have once again included a “Foundations” track which will include selections on the fundamentals of medication assisted treatment.

The conference will continue to be the world’s premier training and education event for the treatment of opioid use disorders.  We hope to see you in Las Vegas!
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️  TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations. We certainly hope that this is helpful and please let us know if you have any questions.
1 week ago
View on Instagram |
1/10
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication https://youtu.be/i6u3qUS95jU
3 weeks ago
View on Instagram |
2/10
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW. #ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
3 weeks ago
View on Instagram |
3/10
💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
💻 Webinar Recording is Now Available AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative. We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. ➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
3 weeks ago
View on Instagram |
4/10
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone. Register ➡️ bit.ly/3Vz1RPE
1 month ago
View on Instagram |
5/10
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  REGISTER ➡ https://conta.cc/3TF9CSQ View the final rule ➡ https://lnkd.in/e_iu-AtG. There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW (Director - CSAT’s Division of Pharmacologic Therapies). The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
1 month ago
View on Instagram |
6/10
Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2024 Conference, �The world’s premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

The 2024 AATOD Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. The registrants are decision-makers with purchasing power for their treatment centers and are looking for new products, services, and information to improve their patient treatment.

To become an exhibitor today —> https://bit.ly/48ZKMRX
Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2024 Conference, �The world’s premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 The 2024 AATOD Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. The registrants are decision-makers with purchasing power for their treatment centers and are looking for new products, services, and information to improve their patient treatment. To become an exhibitor today —> https://bit.ly/48ZKMRX
2 months ago
View on Instagram |
7/10
TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION

💻 View the latest Conference Video Message from AATOD's President, Mark W. Parrino bit.ly/48y815w,
for the most up-to-date details regarding the upcoming #aatod2024 Conference -
The world's premier training conference event for the treatment of Opioid Use Disorder. #OUD 

Registration ➡️ www.aatodconference.com
TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION 💻 View the latest Conference Video Message from AATOD's President, Mark W. Parrino bit.ly/48y815w, for the most up-to-date details regarding the upcoming #aatod2024 Conference - The world's premier training conference event for the treatment of Opioid Use Disorder. #OUD Registration ➡️ www.aatodconference.com
2 months ago
View on Instagram |
8/10
TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION #aatod2024

TODAY is the last day to take advantage of the discounted registration rate. #aatod2024 is the world’s premier training conference event for the treatment of #OUD.

For registration and hotel information ➡️ bit.ly/3Ue57Q6.

We look forward to seeing you in Las Vegas!
TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION #aatod2024 TODAY is the last day to take advantage of the discounted registration rate. #aatod2024 is the world’s premier training conference event for the treatment of #OUD. For registration and hotel information ➡️ bit.ly/3Ue57Q6. We look forward to seeing you in Las Vegas!
3 months ago
View on Instagram |
9/10
#aatod2024 Conference Update. Comprehensive Listing/Descriptions of Workshops, Posters, and Hot Topic Roundtable Conference Sessions are now available ➡️ http://bit.ly/3Ue57Q6.

The workshop committee is pleased to present a dynamic workshop lineup that includes extremely rich and diverse educational content for all disciplines. You will hear from experts who will share the latest research and developments relating to opioid use disorders and treatment. The workshop lineup will include state of the art information on diverse areas of focus such as patient care and best practices, building community partnerships and collaborations, public policy and regulatory changes, workforce development, quality assurance, and financial reimbursement. There will be workshops that focus on emerging treatment trends and developments such as the fentanyl epidemic, mobile opioid treatment programs, regulatory changes, expansion of treatment services in rural areas, integrating treatment with the corrections systems, and integrating harm reduction initiatives. For those newer to the field or those who want a refresher on the basics, we have once again included a “Foundations” track which will include selections on the fundamentals of medication assisted treatment.

The conference will continue to be the world’s premier training and education event for the treatment of opioid use disorders.  We hope to see you in Las Vegas!
#aatod2024 Conference Update. Comprehensive Listing/Descriptions of Workshops, Posters, and Hot Topic Roundtable Conference Sessions are now available ➡️ http://bit.ly/3Ue57Q6. The workshop committee is pleased to present a dynamic workshop lineup that includes extremely rich and diverse educational content for all disciplines. You will hear from experts who will share the latest research and developments relating to opioid use disorders and treatment. The workshop lineup will include state of the art information on diverse areas of focus such as patient care and best practices, building community partnerships and collaborations, public policy and regulatory changes, workforce development, quality assurance, and financial reimbursement. There will be workshops that focus on emerging treatment trends and developments such as the fentanyl epidemic, mobile opioid treatment programs, regulatory changes, expansion of treatment services in rural areas, integrating treatment with the corrections systems, and integrating harm reduction initiatives. For those newer to the field or those who want a refresher on the basics, we have once again included a “Foundations” track which will include selections on the fundamentals of medication assisted treatment. The conference will continue to be the world’s premier training and education event for the treatment of opioid use disorders. We hope to see you in Las Vegas!
3 months ago
View on Instagram |
10/10

OTPs offer life-saving care beyond methadone services. A recent study found that Hepatitis C virus treatment initiated through OTP telehealth visits resulted in faster adoption of direct-acting antiviral therapy and higher cure rates. Learn more: https://ow.ly/I1NQ50RcE9g

Load More...

#aatod2024 Conference – Las Vegas

COUNTDOWN

2024 Conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram
Stay Connected to AATOD